News
The city of Lowell is facing a deepening homelessness crisis, worsened by the ongoing challenges of drug addiction and ...
Hoo Haven Wildlife Rehabilitation and Rescue Center held a wine tasting event to raise money for increased costs during the ...
13h
MedPage Today on MSNSCOTUS to Mull Whether Insurers Must Offer Certain Preventive Services for FreeThe Supreme Court will hear oral arguments Monday in a case that could affect what kind of preventive care is covered at no ...
Eisai Co.’s breakthrough Alzheimer’s drug Leqembi was cleared for use in the European Union, after the medicine was approved in the US and Japan. The European Commission approved the drug to treat ...
Discover How This Advanced Plant-Based Formula Targets the Root Causes of Ear Ringing Through Neuro-Audio Recalibr ...
19h
Verywell Health on MSNOhtuvayre: The First Novel COPD Treatment Approved in Over a DecadeFact checked by Jennifer Klump Ohtuvayre (ensifentrine), a drug approved in 2024 to treat chronic obstructive pulmonary ...
Approval based on Phase 3 trials demonstrating Dupixent significantly reduced itch and hives compared to placebo In the U.S., there are more than ...
Dupixent approved in the US as the first new targeted therapy in over a decade for chronic spontaneous urticaria Approval based on phase 3 studies demonstrating Dupixent significantly reduced itch ...
Early data from the deflection program showed a roughly 16% success rate in its first three months, but data lags and the ...
Dupixent approved in the US as the first new targeted therapy in over a decade for chronic spontaneous urticaria Approval based on phase 3 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results